Med Ad News sat down with Ankit Vahia, Ph.D., who recently joined ConcentricLife as chief strategy officer, to talk about the agency’s strategy behind delivering experiences versus having a transactional relationship with clients and brands.
Tag Archive for: patient engagement
Part IV: Leaders discuss how social media has changed messaging and engagement with patients and HCP, and the role of influencer marketing.
Part VI: Leaders in healthcare marketing and communications share their thoughts on what excites them about the year ahead.
Right now if your inbox is filled with news, commentary, and proposals about the promise of, ethics surrounding, and/or impact of AI, you’re not alone. The technology is touching every business segment, but just how it can be successfully applied in the most rigorous fields, remains to be seen. Med Ad News recently spoke with Steven Hebert, executive VP, business development at Saatchi & Saatchi Wellness about the latest buzz around generative AI.
The introduction of technology interoperability regulations and advancements in artificial intelligence, implementing technology tools can significantly reduce the burden at every level of organization operations. It can also improve the success rates of clinical trials and accelerate the development of new treatment options for the patients who need them.
Most of us engage with social media at least once day. I am being pretty conservative as I write that statement. On a global scale, a person spends an average of 2.25 hours a day on social media. And for those of us who work in media or healthcare communications, we are on and off social media all day, pretty much every day. On this professional scale, we use social media to educate and engage with our audience.
Justin Chase, executive vice president of media, EVERSANA INTOUCH discusses trends in social media how healthcare communicators can leverage different platforms to build stronger relationships with patients and HCPs.
Over the next few years, the most successful organizations will be those that use the current opportunity to rethink their MI workflows and develop hybrid human-AI models.
The combined capabilities will help improve trial lifecycles for patients, sites, and sponsors.
